Skip to main content

Study Looks at Race-Ethnicity-Gender Disparities in Statin Use

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 24, 2023 -- For several race-ethnicity-gender groups, statin use disparities are not explained by measurable differences in medical appropriateness of therapy, access to health care, or socioeconomic status, according to a study published online July 25 in the Annals of Internal Medicine.

David A. Frank, M.P.H., from the University of Pittsburgh School of Public Health, and colleagues estimated disparities in statin use by race-ethnicity-gender and determined whether these are explained by medical appropriateness of therapy and structural factors in a cross-sectional analysis of data from the National Health and Nutrition Examination Survey from 2015 to 2020.

The researchers found that a lower prevalence of statin use was identified for primary prevention in non-Hispanic Black men and non-Mexican Hispanic women, and it was not explained by measurable differences in disease severity or structural factors (adjusted prevalence ratios [aPRs], 0.73 and 0.74, respectively). A lower prevalence of statin use was identified for secondary prevention among non-Hispanic Black men, other/multiracial men, Mexican American women, non-Mexican Hispanic women, non-Hispanic White women, and non-Hispanic Black women (aPRs, 0.81, 0.58, 0.36, 0.57, 0.69, and 0.75, respectively), which was not explained by measurable differences in disease severity or structural factors.

"Because these statin use disparities may contribute to disparities in overall cardiovascular morbidity and mortality, they highlight the importance of societal interventions to health delivery systems to reduce inequity in care delivery and treatment," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

Apple Cider Vinegar Beneficial for Overweight, Obese Individuals

WEDNESDAY, March 13, 2024 -- For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as...

Dyslipidemia Raising Risk for CVD Among Young American Indians

TUESDAY, March 12, 2024 -- Dyslipidemia is associated with subclinical and clinical cardiovascular disease (CVD) among young American Indians, according to a study published...

2015 to 2021 Saw Marked Rise in PCSK9 Inhibitor Utilization

TUESDAY, March 5, 2024 -- Barriers for proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) use persist for cholesterol management, according to a research letter...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.